JDJoanna Nicole D'SOuza

Joanna Nicole D'SOuza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joanna Nicole D'SOuza has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Challenges Associated With Re‐Emergence of Lassa Fever in Nigeria: An Exploratory Study of Epidemiology, Phylogenomics, and Recommendations Toward Its Eradication

    by Ridwan Olamilekan Adesola, Ibrahim Idris, Adetolase Azizat Bakre, Joseph Fosu Arthur, Joanna Nicole D'SOuza

    Background: Lassa fever (LF) is a viral hemorrhagic illness endemic in Nigeria and other West African countries. In recent years, the number of reported cases of LF in Nigeria has increased. In this study, we discussed the epidemiology of LF, the phylogenomics of the LF virus, issues associated with the increased cases of LF, and recommendations for tackling the future occurrence of LF in Nigeria.Methods: Epidemiology data on LF were obtained from the Nigeria Centre for Disease Control database and analyzed using Microsoft Excel software. About 59 partial and complete sequences consisting of both small and large segments of the LF virus were retrieved from the National Center for Biotechnology Information from 1969 to 2013 to study the evolutionary relationship of the LF virus in Nigeria.Results: Nigeria has been shown to have the highest prevalence of Lassa fever among African countries, with seasonal occurrence in both wet and dry seasons. Furthermore, the phylogenetic analysis of the LF virus showed a great relationship with several outbreaks of LF in Nigeria and other African countries.Conclusion: To combat the increasing cases of LF in Nigeria, there is a need to increase the molecular diagnosis capacity in Nigeria, improve public health awareness about the disease in rural and urban settlements, integrate a surveillance system through the One Health lens, and support LF vaccine research in Africa.


  • Open Access

    Marburg virus outbreaks in Africa

    by Ibrahim Idris, Ridwan Olamilekan Adesola, Joanna Nicole D’sOuza

    Marburg virus disease (MVD) is a zoonotic viral hemorrhagic illness, caused by a negative sense, single-stranded RNA virus which has an envelope. The Marburg virus belongs to the genus Marburgvirus of the family Filoviridae. Due to the similarities in clinical signs and symptoms seen in other viral hemorrhagic diseases, arboviral infections, and malaria, MVD is difficult to diagnose. On February 8, 2023, Equatorial Guinea declared the first case of the MVD, which was confirmed by the Institute Pasteur Laboratory, Dakar, Senegal. MVD had a fatality rate of up to 88% during this outbreak. About eight individuals who had suspected infections, as well as the individuals with the confirmed infection, passed away. This letter addresses the current and previous Marburg virus outbreaks in African nations and whether or not they may result in an epidemic. It also discusses the significance of effective biosecurity and quarantine in limiting the spread of a highly contagious illness like MVD in African population.


  • Open Access

    Tomato flu 2022 outbreak in India: Issues, challenges, and possible solutions

    by Ridwan Olamilekan Adesola, Ibrahim Idris, Emmanuel Opuni, Joanna Nicole D'SOuza

    Background and Aims: The outbreak of Tomato flu in India has affected the children making the parents tremble in worry and pain. The outbreak of this disease first occurred in India affecting young children below 5 years of age, thereby causing a threat to the country, neighboring countries, and the rest of the world—although no death is yet recorded. The aim of this research is to discuss the issues, challenges, and possible solutions associated with 2022 Tomato flu outbreaks in India.Results: Tomato flu is caused by Coxsackievirus A16 as confirmed in the United Kingdom. The health authorities are currently monitoring the spread of the virus and trying to understand it to develop strategies to contain it. But they are left with some challenges relating to the health system, surveillance, and adherence to preventive protocols among others.Conclusion: To prevent the spread of Tomato flu to other neighboring countries like China, Bangladesh, Pakistan, Sri Lanka, Myanmar, Afghanistan, Bhutan, Nepal, and the Maldives, the Indian Government must provide adequate public health control measures to contain the disease in children. Various recommendations have been given below.

  • Open Access

    Is monkeypox going to be the next pandemic?

    by Ridwan Olamilekan Adesola, Joanna Nicole D’sOuza, Aisha Bisola Bello, Varaidzo Joyline Mukwekwe

    Background and aims: In the current global scenario, the monkeypox virus has infected over 3000 individuals from endemic countries like Nigeria, along with non-endemic countries like the UK, Canada, the USA, etc. Based on the current information, it has been observed that monkeypox cases have primarily, though not exclusively, been found among men who have sex with men (MSM) in countries such as the UK. This article discusses the recent outbreak of monkeypox, its causes, and the various approaches to combat monkeypox infections. Methods: We evaluated the trends of recent outbreaks of monkeypox in different countries and compared them to how the COVID-19 pandemic started. Results: At present, monkeypox has been reported to spread to over 58 countries via skin-to-skin contact, body fluids, contaminated bed sheets, clothing, or respiratory routes. Smallpox vaccines have been proven to have 85% efficacy against monkeypox. To mitigate this current outbreak, WHO urges people to practice good hygiene and safe sex. The documentation of more cases and further onward spread in the countries in member states are most likely to reoccur, and if not contained, we might experience another global pandemic. Therefore, more research is required to avert this problem. Conclusion: Monkeypox virus is testing if we have complied with COVID-19 pandemic lessons and elucidates the urgency of research required to understand the monkeypox disease.